Cascadian Therapeutics Announces Proposed Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Cascadian Therapeutics (CASC) Offering said to be at $0.80/Share - Feuerstein
June 22, 2016 6:09 PM EDTCascadian Therapeutics (NASDAQ: CASC) stock offering price said to be $0.80 per share, according to The Street's Adam Feuerstein.
$CASC stock offering pricing at 80 cents per share, source tells me. BVF and one other investor buying 75% of the deal, Im told.
Adam Feuerstein (@adamfeuerstein) June 22, 2016... More